Emerson Electric Company (EMR) Gets a Buy from Argus Research
In a report released on May 8, from Argus Research maintained a Buy rating on Emerson Electric Company, with a price target of $175.00.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
In addition to Argus Research, Emerson Electric Company also received a Buy from KeyBanc’s Kenneth Newman in a report issued on May 6. However, on May 8, Wells Fargo reiterated a Hold rating on Emerson Electric Company (NYSE: EMR).
Based on Emerson Electric Company’s latest earnings release for the quarter ending March 31, the company reported a quarterly revenue of $4.56 billion and a net profit of $618 million. In comparison, last year the company earned a revenue of $4.43 billion and had a net profit of $485 million
Based on the recent corporate insider activity of 66 insiders, corporate insider sentiment is negative on the stock. This means that over the past quarter there has been an increase of insiders selling their shares of EMR in relation to earlier this year. Most recently, in March 2026, Surendralal Lanca Karsanbhai, the President & CEO of EMR sold 5,700.00 shares for a total of $811,224.00.
Read More on EMR:
Disclaimer & DisclosureReport an Issue
- Emerson price target raised to $144 from $140 at Barclays
- Emerson price target raised to $169 from $161 at RBC Capital
- Christopher Snyder Initiates Sell on Emerson Amid Cut Growth Outlook and Questionable Second‑Half Reacceleration
- Emerson Electric Earnings Call Highlights Profitable Resilience
- Emerson Electric Posts Strong Q2 Results, Reaffirms 2026 Outlook
